- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To collect follow-up safety data from patients in completed abiraterone acetate studies. Consideration will be given to extending the duration of the study following review of the safety data at 3 years.
Critère d'inclusion
- Metastatic Castration-Resistant Prostate Cancer (PCR)